01064naa a2200253 a 450000100080000000500110000800800410001902400380006010000200009824501110011826000090022952003120023865000140055065300170056470000220058170000200060370000200062370000180064370000200066170000210068170000220070270000190072477300670074320376732016-02-19       2015    bl uuuu     u00u1 u    #d7 a10.1016/j.schres.2015.10.0182DOI1 aBRITO, R. B. de  aThe CYP1A2 - 163CNA polymorphism is associated with super-refractory schizophrenia.h[electronic resource]  c2015  aConsidering that there are few studies regarding the influence of the CYP1A2*1F polymorphism and the clinical response to clozapine, we investigated the influence of CYP1A2*1F (- 163CNA&gtA, rs762551) polymorphism in refractory and super-refractory schizophrenic patients in a naturalistic clinical setting.  aGenótipo  aPoliformismo1 aARAÚJO, L. de C.1 aDINIZ, M. J. A.1 aGEORG, R. de C.1 aNABOUT, J. C.1 aVIANELLO, R. P.1 aSANTOS, R. da S.1 aCRUZ, A. H. da S.1 aGHEDINI, P. C.  tSchizophrenia Researchgv. 169, n. 1/3, p. 502-503, Dec. 2015.